Correlation Between Innovative Medical and China Molybdenum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovative Medical and China Molybdenum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovative Medical and China Molybdenum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovative Medical Management and China Molybdenum Co, you can compare the effects of market volatilities on Innovative Medical and China Molybdenum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovative Medical with a short position of China Molybdenum. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovative Medical and China Molybdenum.

Diversification Opportunities for Innovative Medical and China Molybdenum

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Innovative and China is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Innovative Medical Management and China Molybdenum Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Molybdenum and Innovative Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovative Medical Management are associated (or correlated) with China Molybdenum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Molybdenum has no effect on the direction of Innovative Medical i.e., Innovative Medical and China Molybdenum go up and down completely randomly.

Pair Corralation between Innovative Medical and China Molybdenum

Assuming the 90 days trading horizon Innovative Medical Management is expected to generate 1.58 times more return on investment than China Molybdenum. However, Innovative Medical is 1.58 times more volatile than China Molybdenum Co. It trades about 0.03 of its potential returns per unit of risk. China Molybdenum Co is currently generating about 0.03 per unit of risk. If you would invest  739.00  in Innovative Medical Management on November 9, 2024 and sell it today you would earn a total of  146.00  from holding Innovative Medical Management or generate 19.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Innovative Medical Management  vs.  China Molybdenum Co

 Performance 
       Timeline  
Innovative Medical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Innovative Medical Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
China Molybdenum 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days China Molybdenum Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Innovative Medical and China Molybdenum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovative Medical and China Molybdenum

The main advantage of trading using opposite Innovative Medical and China Molybdenum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovative Medical position performs unexpectedly, China Molybdenum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Molybdenum will offset losses from the drop in China Molybdenum's long position.
The idea behind Innovative Medical Management and China Molybdenum Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years